A comparison of the Niagara™ and Medcomp™ catheters for continuous renal replacement therapy

Renal Failure

Volumn 35, Issue 3, 2013, Pages 308-313

  Fealy, Nigel ^a   Kim, Inbyung ^b   Baldwin, Ian ^a   Schneider, Antoine ^a   Bellomo, Rinaldo ^a  

^a AUSTIN HOSPITAL   (Australia)

^b Catholic Kwandong University   (South Korea)

Author keywords

Acute kidney failure; Continuous hemofiltration; Continuous renal replacement therapy; Critical care; Double lumen catheter; Filter life

Indexed keywords

HEPARIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CATHETER; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTINUOUS RENAL REPLACEMENT THERAPY; FEMALE; FILTER; HEMOGLOBIN DETERMINATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; PARTIAL THROMBOPLASTIN TIME; PREDICTIVE VALUE; PRIORITY JOURNAL; THROMBOCYTE COUNT; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; COMPARATIVE STUDY; CRITICAL ILLNESS; DEVICES; FEMORAL VEIN; INTENSIVE CARE; MIDDLE AGED; PILOT STUDY; RENAL REPLACEMENT THERAPY; SURGERY;

ADULT; AGED; CRITICAL CARE; CRITICAL ILLNESS; FEMALE; FEMORAL VEIN; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RENAL REPLACEMENT THERAPY; VASCULAR ACCESS DEVICES;

EID: 84875008797     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.757823     Document Type: Article

References (22)

1. Uchino S, Bellomo R, Morimatsu H, et al. Continuous renal replacement therapy: A worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med. 2007;33:1563-1570
2. Vanholder R, Van Biesen W, Lameire N. What is the renal replacement method of first choice for intensive care patients? J Am Soc Nephrol. 2001;12:S40-S43
3. Ronco C, Cruz D, Bellomo R. Continuous renal replacement therapy in critical illness. Contrib Nephrol. 2007;156:309-319
4. Schetz M. Vascular access for IHD and CRRT. Contrib Nephrol. 2007;156:275-286
5. Wentling AG. Hemodialysis catheters: Materials, design and manufacturing. Contrib Nephrol. 2004;142:112-127
6. Savader SJ, Haikal LC, Ehrman KO, Porter DJ, Oteham AC. Hemodialysis catheter-Associated fibrin sheaths: Treatment with a low-dose rt-PA infusion. J Vasc Interv Radiol. 2000;11:1131-1136
7. Oliver MJ, Mendelssohn DC, Quinn RR, et al. Catheter patency and function after catheter sheath disruption: A pilot study. Clin J Am Soc Nephrol. 2007;2:1201-1206
8. Grudzinski L, Quinan P, Kwok S, Pierratos A. Sodium citrate 4% locking solution for central venous dialysis catheters-An effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant. 2007;22:471-476
9. Vanholder R. Vascular access: Care and monitoring of function. Nephrol Dial Transplant. 2001;16:1542-1545
10. Schindler R, Heemann U, Haug U, et al. Bismuth coating of non-tunneled hemodialysis catheters reduces bacterial colonization: A randomized controlled trial. Nephrol Dial Transplant. 2010;25:2651-2656
11. Baumann M, Witzke O, Dietrich R, et al. Prolonged catheter survival in intermittent hemodialysis using a less thrombogenic micro-patterned polymer modification. ASAIO J. 2003;49:708-712
12. Meier P, Meier R, Turini P, Friolet R, Blanc E. Prolonged catheter survival in patients with acute kidney injury on continuous renal replacement therapy using a less thrombogenic micro-patterned polymer modification. Nephrol Dial Transplant. 2011;26:628-635
13. Parienti JJ, Thirion M, Mégarbane B, et al.; Members of the Cathedia Study Group. Femoral vs. jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: A randomized controlled trial. JAMA. 2008;299:2413-2422
14. NakaT, EgiM,BellomoR, Baldwin I, FealyN,Wan L.Resistance of vascular access catheters for continuous renal replacement therapy: An ex-vivo evaluation. Int J Artif Organs. 2008;31:905-909
15. Tan HK, Bridge N, Baldwin I, Bellomo R. An ex-vivo evaluation of vascular access catheters for continuous hemofiltration. Ren Fail. 2002;24:755-762
16. Unger JK,HalternC, PortzB,DohmenB,GressnerA,RossaintR. Relation of hemofilter type to venous catheter resistance is crucial for filtration performance and hemocompatibility in CVVH-An in vitro study. Nephrol Dial Transplant. 2006;21:2191-2201
17. Unger JK, Pietzner K, Francis RC, et al. Dual lumen catheters for continuous veno-venous hemofiltration: Limits for blood delivery via femoral vein access and a potential alternative in an experimental setting in anaesthetized pigs. Crit Care. 2007;11:R18
18. Parienti JJ, Mégarbane B, Fischer MO, et al.; Cathedia Study Group. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: A randomized controlled study. Crit Care Med. 2010;38:1118-1125
19. Brain M, Parkes S, Fowler R, Robertson I, Brown A. Calcium flux in continuous veno-venous hemofiltration with heparin and citrate anticoagulation. Crit Care Resusc. 2011;13:72-82
20. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365:147-156
21. Agarwal B, Shaw S, Hari MS, Burroughs AK, Davenport A. Continuous renal replacement therapy in patients with liver disease: Is circuit life different? J Hepatol. 2009;51: 504-509
22. Wright BJ. The RENAL replacement therapy study investigators. Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627-1638